Skip to Content

SZ 327 (Mycophenolate Mofetil 500 mg)

Pill with imprint SZ 327 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 327

Mycophenolate mofetil 500 mg SZ 327

Mycophenolate Mofetil

Imprint
SZ 327
Strength
500 mg
Color
Purple
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
Inactive Ingredients
croscarmellose sodium, hydroxypropyl cellulose (type h), hypromelloses, ferrosoferric oxide, ferric oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00781-5175 Sandoz Inc.
68084-0801 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.